Literature DB >> 1972348

Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.

R Pfragner1, H Höfler, A Behmel, E Ingolic, V Walser.   

Abstract

Tumor cells of a human medullary thyroid carcinoma were isolated and propagated in tissue culture. Several cell lines with different morphology developed from the primary culture, among others a fibroblast-like growing cell line (MTC-F) and a cell line growing as a suspension of single cells and spherical cell clusters (MTC-SK). The MTC-SK cell line was serially propagated for 90 passages, over 3 years. When examined at different times throughout the in vitro period, MTC-SK exhibited properties characteristic of medullary thyroid carcinomas: the cells maintained their epithelioid morphology; endocrine granules were demonstrated in the cytoplasm by electron microscopy; in situ hybridization confirmed the production of calcitonin- and bombesin-mRNA (gastrin releasing peptide); the cells revealed positive immunoreactivity with antibodies to calcitonin, calcitonin gene-related peptide, and bombesin. The in vitro properties of the MTC-SK cells corresponded to the results obtained from the tissue of origin. Cytogenetic studies of the MTC-F cell line revealed a supernumerary metacentric chromosome (20?). In the MTC-SK cell line the predominant findings were terminal chromosomal rearrangements most frequently concerning chromosome 11p, i.e., the locus of the calcitonin and calcitonin gene-related peptide genes and the H-ras oncogene, and a characteristic instability of the centromeric region of chromosome 16 and somatic pairing of the homologous chromosomes 16.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  The role of Cdk5 in neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Emely Castro-Rivera; Chunfeng Tan; Florian Plattner; Gert Schwach; Veronika Siegl; Douglas Meyer; Ailan Guo; Justin Gundara; Gabriel Mettlach; Edmond Richer; Jonathan A Guevara; Li Ning; Anjali Gupta; Guiyang Hao; Li-Huei Tsai; Xiankai Sun; Pietro Antich; Stanley Sidhu; Bruce G Robinson; Herbert Chen; Fiemu E Nwariaku; Roswitha Pfragner; James A Richardson; James A Bibb
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

2.  Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells.

Authors:  Victor Aguiriano-Moser; Bernhard Svejda; Zeng-Xia Li; Sonja Sturm; Hermann Stuppner; Elisabeth Ingolic; Harald Höger; Veronika Siegl; Nathalie Meier-Allard; Anton Sadjak; Roswitha Pfragner
Journal:  Mol Med Rep       Date:  2015-07-07       Impact factor: 2.952

3.  Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.

Authors:  Karine Pozo; Antje Hillmann; Alexander Augustyn; Florian Plattner; Tao Hai; Tanvir Singh; Saleh Ramezani; Xiankai Sun; Roswitha Pfragner; John D Minna; Gilbert J Cote; Herbert Chen; James A Bibb; Fiemu E Nwariaku
Journal:  Oncotarget       Date:  2015-05-20

4.  Characteristics of a thyroid carcinoma cell line derived from spinal metastasis.

Authors:  Zhenhua Zhou; Yan Li; Xu Yan; Xudong Wang; Su Chen; Jianru Xiao
Journal:  Biosci Rep       Date:  2016-12-09       Impact factor: 3.840

5.  A Droplet Microfluidics Based Platform for Mining Metagenomic Libraries for Natural Compounds.

Authors:  Elias Theodorou; Randall Scanga; Mariusz Twardowski; Michael P Snyder; Eric Brouzes
Journal:  Micromachines (Basel)       Date:  2017-07-25       Impact factor: 2.891

6.  The dichloromethane fraction of Stemona tuberosa Lour inhibits tumor cell growth and induces apoptosis of human medullary thyroid carcinoma cells.

Authors:  Zengxia Li; Sonja Sturm; Hermann Stuppner; Elisabeth Schraml; Victor Aguiriano Moser; Veronika Siegl; Roswitha Pfragner
Journal:  Biologics       Date:  2007-12

7.  Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Stefan Zahler; Keisuke Ishimatsu; Angela M Carter; Rahul Telange; Chunfeng Tan; Shuaijun Wang; Roswitha Pfragner; Junya Fujimoto; Elizabeth Gardner Grubbs; Masaya Takahashi; Sarah C Oltmann; James A Bibb
Journal:  Oncotarget       Date:  2018-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.